نویسندگان
دانشگاه علوم پزشکی گیلان
چکیده
خلاصه
پیشزمینه: تاخیر در تشخیص یا درمان نامناسب تومورهای خوشخیم استخوانی، منجر میشود که برخی از آنها تبدیل به تومورهای بدخیم شوند و یا باعث آسیب به سایر ارگانهای داخلی گردند. در این مطالعه ما برآن شدیم که انواع تومورهای خوشخیم استخوانی و عوامل مرتبط با آن در بازه زمانی ده ساله در بیماران مراجعه کننده به بخشهای ارتوپدی بیمارستان پورسینای رشت، را بررسی نمائیم.
مواد و روشها: در این مطالعه توصیفی – مقطعی پرونده کلیه بیماران با ضایعات تومورال خوشخیم بستری شده در بخش ارتوپدی مرکز آموزشی درمانی پورسینا، در بازه زمانی 10 ساله (1396-1386)، با استفاده از روش سرشماری مورد بررسی قرار گرفتند. اطلاعات دموگرافیکی، یافتههای کلینیکی و یافتههای پاراکلینیکی با استفاده از چک لیست جمعآوری گردید.
یافتهها: میانگین سنی مبتلایان به تومورهای خوشخیم استخوانی مورد تحقیق برابر 93/12±5/43 سال بود. بیشترین درصد مبتلایان به تومورهای خوشخیم استخوانی را مردان تشکیل میدادند (9/63%). تومورهای خوشخیم مولتی پلاگزوستوزیس (25%)، استئوکوندروما (2/22%) و استوئید استوما (7/16%) به ترتیب بیشترین فراوانی را داشتند. با استفاده از آزمون Fisher’s exact test مشخص گردید که ارتباط آماری معنیداری بین جنسیت، ردههای سنی، محل تومور با انواع تومورهای خوشخیم استخوان در بیماران مورد تحقیق دیده میشود.
نتیجهگیری: مولتی پلاگزوستوزیس و استئوکوندروما شایعترین تومورها بودند. متغیرهایی از قبیل جنسیت، ردههای سنی به عنوان عوامل خطر موثر در ابتلا به تومورهای خوشخیم استخوانی شناسایی شدند.
کلیدواژه‌ها
عنوان مقاله [English]
Frequency of Benign Bone Tumor Referred to a Teaching Hospital in Northern Iran
نویسندگان [English]
- Amir Salari
- Kamran Asadi
- Ali Bahari-Khorram
چکیده [English]
Abstract
Introduction: A delay in diagnosis and inadequate treatment of Benign bone tumors may lead to malignant transformation or damage to other internal organs with time. We decided to Survey the frequency of benign bone tumors and its related factors in patients in a ten-year period referred to Orthopaedic ward of Poursina Hospital, Rasht.
Materials and Methods: A descriptive retrospective study was designed on bone tumors collected from medical records of 2007 – 2017 patients referred to Guilan university of medical sciences. All the demographic data were collected and analyzed.
Results: The mean age of patients with benign tumors of bone in this investigation was the 43.5 ± 12.93 years. The highest percentage of patients with benign tumors of bone were males (63.9%). The highest percentage of benign tumor of bone was multiple exostosis 25% followed by osteochondroma 22.2% and then osteoid stoma by 16.7%. Using Fisher's exact test showed a statistically significant relationship between gender, age, educational level and location of the benign tumors of bone seen in this study (P=0.001).
Conclusion: Exotosis and osteochondroma are the most common benign bone tumors, and are more in the lower limb in the male gender -Blood pressure and higher education level were the common associated findings.
کلیدواژه‌ها [English]
- Keywords: Benign Bone Tumors
- Multiple Exostoses
- Osteochondroma
- Orthopedic Ward
statistics, 2013. CA Cancer J Clin. 2013;63:11-30.
2- Bray F, Jemal A, Grey N, Ferlay J, Forman D.
Global cancer transitions according to the Human
Development Index (2008-2030): a population-based
study. Lancet Oncol. 2012;13:790-801.
3- Ferlay J, Soerjomataram I, Ervik M, Dikshit R,
Eser S, Mathers C, et al. GLOBOCAN 2014 v1.0, cancer
incidence and mortality worldwide: IARC Cancer- Base
No. 11 [Internet]. Lyon, France: International Agency for
Research on Cancer;c2013, [accessed 26 Aug 2014].
Available from:http://globocan.iarc.fr
4- Bradley CJ, Yabroff KR, Dahman B, Feuer EJ,
Mariotto A, Brown ML. Productivity costs of cancer
mortality in the United States: 2000-2020. J Natl Cancer
Inst. 2008;100:1763-70.
5- Forest M, Tomeno B, Vanel D. Orthopedic
surgical pathology: Diagnosis of tumors and
pseudotumoral lesions of bone and joint. 7thed.
Philaphia, Academic Press, 2009.
6- Steffner R. Benign bone tumors. Cancer Treat
Res. 2014;162:31-63.
7- Riedel RF, Larrier N, Dodd L, Kirsch D, Martinez
S, Brigman BE. The clinical management of
chondrosarcoma. Curr Treat Options Oncol. 2009;10:94-
106.
8- Frassica FJ, Waltrip RL, Sponseller PD, Ma LD,
McCarthy EF, Jr. Clinicopathologic features and
treatment of osteoid osteoma and osteoblastoma in
children and adolescents. Orthop Clin North Am.
1996;27:559-74.
9- Hakim DN, Pelly T, Kulendran M, Caris JA.
Benign tumours of the bone: A review. J Bone Oncol.
2015;4:37-41.
10- Munoz-Bendix C, Cornelius JF, Bostelmann R,
Gierga K, Steiger HJ. Giant cell tumor of the lumbar
spine with intraperitoneal growth: Case report and
review of literature. Acta Neurochir (Wien).
2013;155:1223-8.
11- Franchi A. Epidemiology and classification of
bone tumors. Clin Cases Miner Bone Metab. 2012;9:92-
5.
12- Wyers MR. Evaluation of pediatric bone lesions.
Pediatr Radiol. 2010;40:468-73.
13- Eyesan SU, Idowu OK, Obalum DC, Nnodu OE,
Abdulkareem FB. Surgical consideration for benign bone
tumors. Niger J Clin Pract. 2011;14:146-50.
14- Minami A, Kato H, Nagai M. Recurrent benign
chondroblastoma at the distal end of the radius. J Hand
Surg Br. 1999;24:113-5.
15- Temple HT, Malinin TI. Microparticulate cortical
allograft: an alternative to autograft in the treatment of
osseous defects. Open Orthop J. 2008;2:91-6.
bone tumors and tumor-like lesions.1st ed. Heidelberg,
Springer-Verlag Berlin Heidelberg, 2009.
17- Townsend C, Beauchamp RD, Evers BM, Mattox
K. Sabiston textbook of surgery: The biological basis of
modern surgical practice. Philadelphia, Saunders
Elsevier, 2010.
18- Vlychou M, Athanasou NA. Radiological and
pathological diagnosis of paediatric bone tumours and
tumour-like lesions. Pathology. 2008;40:196-216.
19- Goedhart LM, Ploegmakers JJ, Kroon HM,
Zwartkruis EC, Jutte PC. The presentation, treatment
and outcome of periosteal chondrosarcoma in the
Netherlands. Bone Joint J. 2014;96-b:823-8.
20- Roudbari S, Haji Aliloo Sami S, Roudbari M. The
clinical results of benign bone tumor treatment with
allograft or autograft. Arch Iran Med. 2015;18:109-13.
21- Bergovec M, Kubat O, Smerdelj M, Seiwerth S,
Bonevski A, Orlic D. Epidemiology of musculoskeletal
tumors in a national referral orthopedic department. A
study of 3482 cases. Cancer Epidemiol. 2015;39:298-
302.
22- Mazloumi SM, Ebrahimzadeh MH, Makhmalbaf
H, Mahdavian SA. Prevalence of benign bone tumors in
our referral orthopedic clinic over the 10 years. Medical
Journal of Mashhad University of Medical Sciences.
2013;56:113-7.
23- Baena-Ocampo Ldel C, Ramirez-Perez E,
Linares-Gonzalez LM, Delgado-Chavez R. Epidemiology
of bone tumors in Mexico City: Retrospective
clinicopathologic study of 566 patients at a referral
institution. Ann Diagn Pathol. 2009;13:16-21.
24- Solooki S, Vosoughi AR, Masoomi V.
Epidemiology of musculoskeletal tumors in Shiraz, south
of Iran. Indian J Med Paediatr Oncol. 2011;32:187-91.
25- pakpour Haji Agha A, Yekani Nejhad MS,
Khoshnevisan A, Nikobakht M, Mardani A, Kamali
Ardakani S. Health related quality of life associated
factors among patients with brain tumors. Journal of
Ilam University of Medical Sciences. 2013;21(3):1-11.
26- Niu X, Xu H, Inwards CY, Li Y, Ding Y, Letson GD,
et al. Primary bone tumors: Epidemiologic comparison
of 9200 patients treated at Beijing Ji Shui Tan Hospital,
Beijing, China, with 10 165 patients at Mayo Clinic,
Rochester, Minnesota. Arch Pathol Lab Med.
2015;139:1149-55.
27- Garcha AS, Gumaste P, Cherian S, Khanna A.
Hypercalcemia: An unusual manifestation of uterine
leiomyoma. Case Rep Med. 2013;2013:815252.
Referen
1. Stein‐Zamir, C., et al., Developmental dysplasia of
the hip: risk markers, clinical screening and outcome.
Pediatrics International, 2008. 50(3): p. 341-345.
2 Pediatrics, A.A.o., Clinical practice guideline: early
دوره هفدهم، شماره 1 (شماره مسلسل 64)، زمستان 1397، صفحه‌های 19-14 بررسی فراوانی انواع تومورهای خوشخیم استخوانی و عوامل مرتبط
با آن ...
detection of developmental dysplasia of the hip. Pediatrics,
2000. 105(4): p. 896-905.
3 Gray, A., et al., Economic evaluation of
ultrasonography in the diagnosis and management of
developmental hip dysplasia in theUnited Kingdom and
Ireland. J Bone Joint Surg Am, 2005. 87(11): p. 2472-2479.
4 Elbourne, D., et al., Ultrasonography in the diagnosis
and management of developmental hip dysplasia (UK Hip
Trial): clinical and economic results of a multicentre
randomised controlled trial. The Lancet, 2002. 360(9350): p.
2009-2017.
5 Studer, K., et al., Increase in late diagnosed
developmental dysplasia of the hip in South Australia: risk
factors, proposed solutions. The Medical Journal of Australia,
2016. 204(6): p. 240.
6. Thallinger, C., et al., Long-term results of a
nationwide general ultrasound screening system for
developmental disorders of the hip: the Austrian hip screening
program. Journal of children's orthopaedics, 2014. 8(1): p. 3-
10.
7 El Hage, S., et al., Is percutaneous adductor
tenotomy as effective and safe as the open procedure? Journal
of Pediatric Orthopaedics, 2010. 30(5): p. 485-488.
8 Tönnis, D., An evaluation ofconservative and
operative methods in the treatment of congenital hip
dislocation. Clinical orthopaedics and related research, 1976.
119: p. 76-88.
9 Schramm, M., et al., The Wagner spherical
osteotomy of the acetabulum. J Bone Joint Surg Am,
2004(suppl 1): p. 73-80.
10 Sankar, W.N., Gorniltzky al,clark AL., Closed
Reduction for Developmental Dysplasia of the Hip: Early-term
Results From a Prospective, Multicenter Cohort. Journal of
pediatric orthopedics, 2019.
11 Tennant, S., et al., A protocol for the use of
closedreduction in children with developmental dysplasia of the
hip incorporating open psoas and adductor releases and a
short-leg cast: Mid-term outcomes in 113 hips. Bone Joint J,
2016. 98(11): p. 1548-1553.
12 Barakat, A.S., et al., Closed reduction with orwithout
adductor tenotomy for developmental dysplasia of the hip
presenting at walking age. Current orthopaedic practice, 2017.
28(2): p. 195.
.13. Kalamchi A, MacEwen GD: Avascular
necrosis following treatment
of congenital dislocation of the hip, J Bone Joint
Surg Am
)